ICU Medical Executive and Leadership Team

Brian Bonnell, the Chief Financial Officer at ICU Medical, manages the fiscal health and capital allocation strategies for the global medical device portfolio. Overseeing financial planning, reporting, and investor relations, the Chief Financial Officer ensures the company maintains a robust balance sheet to support ongoing innovation in IV therapy. This leadership role involves navigating the complex financial integration of recent acquisitions to maximize shareholder value. By executing disciplined cost management and revenue growth initiatives, Brian Bonnell directly impacts the long-term financial stability of the organization. The Chief Financial Officer works closely with the executive team to evaluate market opportunities and allocate resources toward high-value critical care products. Through rigorous financial oversight, Bonnell supports the expansion of operations into new home care and hospital markets. This strategic financial stewardship enables the company to sustain its competitive position while delivering consistent value to stakeholders across the global healthcare landscape.

Dan Woolson, the President at ICU Medical, oversees the daily operations and strategic execution of the global business units. Managing the integration of critical care and IV therapy product lines, the President ensures operational excellence across all manufacturing and distribution channels. This leadership role involves coordinating cross-functional teams to drive growth in hospital, alternate site, and home care markets. By streamlining internal processes and fostering a culture of innovation, Dan Woolson directly impacts the company's ability to deliver high-value solutions to healthcare providers. The President works with the executive leadership team to refine market strategies and expand the company's footprint in key geographic regions. Through decisive operational management, Woolson supports the achievement of corporate objectives and long-term sustainability. This focus on execution enables the organization to maintain its market-leading position while consistently providing clinicians with the essential tools required for modern patient care.

Ben Sousa, the Chief Information Officer at ICU Medical, directs the digital infrastructure supporting global IV therapy and critical care manufacturing. Overseeing enterprise-wide data security and systems integration, the Chief Information Officer ensures seamless connectivity across hospital and alternate site care settings. This leadership role involves architecting scalable cloud platforms to support the complex supply chain requirements following recent acquisitions. By optimizing internal data workflows, Ben Sousa directly impacts the operational efficiency of the entire organization. The Chief Information Officer collaborates with the Board to align technological investments with long-term growth objectives. Through the implementation of advanced analytics, Sousa secures the digital integrity of critical care product distribution. This strategic focus on information technology enables the company to maintain consistent quality standards while expanding market reach across diverse healthcare environments, ultimately driving innovation in medical device connectivity and data-driven patient care outcomes.

Jesús Cabrera, the Chief Medical Officer at ICU Medical, leads clinical strategy and safety initiatives for the entire suite of IV therapy and critical care products. Overseeing medical affairs and regulatory compliance, the Chief Medical Officer ensures all innovations meet the highest standards for hospital and home care settings. This leadership role involves guiding clinical research and development to solve real-world challenges faced by healthcare providers. By bridging the gap between medical science and product engineering, Jesús Cabrera directly impacts the safety and efficacy of the company's clinical solutions. The Chief Medical Officer collaborates with global health authorities to validate new technologies and support market expansion. Through continuous clinical evaluation, Cabrera maintains the integrity of the product line. This focus on medical excellence allows the company to provide clinicians with reliable tools, ultimately improving patient outcomes and reinforcing the organization's reputation as a leader in the medical device industry.